Urinary Incontinence in Dogs: Welfare Management

Key Welfare Considerations

• USMI is the most common cause of urinary incontinence in spayed female dogs, affecting approximately 20% of large breed spayed females.
• Incontinence causes urine scalding, skin irritation, and welfare impacts from chronic moisture exposure.
• Oestrogen deficiency following spaying weakens urethral sphincter tone causing involuntary welfare leakage.
• Clinical signs include passive urine leakage during sleep or rest — dogs are often unaware of the welfare event.
• Phenylpropanolamine (PPA) increases urethral sphincter tone and resolves incontinence in 75-85% of affected dogs.
• Estriol hormone supplementation provides welfare benefit for USMI through local receptor activation.
• Combination therapy with PPA and estriol improves welfare outcomes in refractory cases.
• GnRH agonist implants (deslorelin) can restore some urethral sphincter function welfare in some dogs.
• Colposuspension surgery repositions the bladder neck improving urethral closure welfare mechanism.
• Urethral bulking agent injection provides physical support to the urethral sphincter for welfare.
• Ectopic ureter is a congenital welfare cause requiring surgical correction in young dogs.
• Hygiene management with frequent bathing prevents welfare skin complications from urine exposure.
• Waterproof dog pants protect bedding and welfare through moisture barrier management.
• Spaying timing does not eliminate USMI risk — welfare risk is higher with early spay in large breeds.
• Quality of life for incontinent dogs on appropriate treatment is excellent — welfare outcomes are very good.